Inter-relationships between body mass index, C-reactive protein and blood pressure in a hispanic pediatric population

American Journal of Hypertension

Volumn 21, Issue 5, 2008, Pages 527-532

  López Jaramillo, Patricio ^a,b   Herrera, Elizabeth ^c   Garcia, Ronald G ^a   Camacho, Paul A ^a   Castillo, Victor R ^a  

^a FUNDACIÓN CARDIOVASCULAR DE COLOMBIA   (Colombia)

^b UNIVERSIDAD DE SANTANDER   (Colombia)

^c UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; LIPID;

ARTICLE; BLOOD PRESSURE; BODY MASS; CHILDHOOD DISEASE; COLOMBIA; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HISPANIC; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SCHOOL CHILD; SKINFOLD THICKNESS; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADIPOSITY; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHILD; COLOMBIA; FEMALE; HISPANIC AMERICANS; HUMANS; HYPERTENSION; INFLAMMATION; LIPIDS; MALE; NUTRITIONAL STATUS; OBESITY;

EID: 42549091991     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2007.86     Document Type: Article

References (44)

1. Strauss RS, Pollack H. Epidemic increase in childhood overweight, 1986-98. JAMA 2001; 286:2845-2848.
2. López-Jaramillo P, Pradilla LP, Castillo VR, Lahera V. Socioeconomic Pathology as a cause of regional differences in the prevalence of metabolic syndrome and pregnancy-induced hypertension. Rev Esp Cardiol 2007; 60:168-178.
3. Caballero B. A nutrition paradox - underweight and obesity in developing countries. N Engl J Med 2005; 352:1514-1516.
4. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288:1728-1732.
5. Dietz WH. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 1998; 101:518-525.
6. Caprio S. Insulin resistance in childhood obesity. J Pediatr Endocrinol Metab 2002; 15:487-492.
7. Goran MI, Ball GD, Cruz ML. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 2003; 88:1417-1427.
8. Arslanian S. Type 2 diabetes in children: clinical aspects and risk factors. Horm Res 2002; 57:19-28.
9. Berenson GS, Srinivasan SR, Bao W, Newman WP, III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338:1650-1656.
10. Burke V, Beilin LJ, Dunbar D. Tracking of blood pressure in Australian children. J Hypertens 2001; 19:1185-1192.
11. Ribeiro J, Guerra S, Pinto A, Oliveira J, Duarte J, Mota J. Overweight and obesity in students and adolescents: relationship with blood pressure, and physical activity. Ann Hum Biol 2003; 30:203-213.
12. Falkner B, Gidding SS, Ramirez-Garnica G, Wiltrout SA, West D, Rappaport EB. The relationship of body mass index and blood pressure in primary care pediatric patients. J Pediatr 2006; 148:195-200.
13. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112:1785-1788.
14. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102:42-47.
15. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350:1387-1397
16. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D'Agostino RB, Franzblau C, Wilson PW. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001; 32:2575-2579.
17. Ford ES. C-Reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2003; 108:1053-1058.
18. Gillum RF. Association of serum C-reactive protein and indices of body fat distribution and overweight in Mexican American children. J Natl Med Assoc 2003; 95:545-552.
19. Bautista LE, López-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 2001; 19:857-861.
20. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C reactive protein, interleukin-6, and TNF-α) and essential hypertension. J Hum Hypertens 2005; 19:149-154.
21. National High Blood Pressure Education Program Working Group. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 2004; 114:555-576.
22. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low-grade systemic inflammation in overweight children. Pediatrics 2001; 107:E13.
23. Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, Miller GJ, Stracham DP. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 2000; 149:139-150.
24. Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 1990; 7:147-159.
25. Aeberli I, Molinari L, Spinas G, Lehmann R, l'Allemand D, Zimmermann MB. Dietary intakes of fat and antioxidant vitamins are predictors of subclinical inflammation in overweight Swiss children. Am J Clin Nutr 2006; 84:748-755.
26. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350:2362-2374.
27. Perez M, Casas JP, Cubillos-Garzon LA, Serrano NC, Silva F, Morillo CA, López-Jaramillo P. Using waist circumference as a screening tool to identify Colombian subjects at cardiovascular risk. Eur J Cardiovasc Prev Rehabil 2003; 10:328-335.
28. Garcia RG, Cifuentes AE, Caballero RS, Sanchez L, Lopez-Jaramillo P. A proposal for an appropriate central obesity diagnosis in Latin American population. Int J Cardiol 2006; 110:263-264.
29. Lear SA, Chen MM, Birmingham L, Frohlich JJ. The relationship between simple anthropometric indices and C-reactive protein: ethnic and gender differences. Metabolism 2003; 52:1542-1546.
30. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, Wians FH, Grundy SM, de Lemos JA. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005; 46:464-469.
31. Lambert M, Delvin EE, Paradis G, O'Loughlin J, Hanley JA, Levy E. C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin Chem 2004; 50:1762-1768.
32. Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 1996; 143:228-239.
33. He Q, Horlick M, Thornton J, Wang J, Pierson RN, Heshka S, Gallagher D. Sex-specific fat distribution is not linear across pubertal groups in a multiethnic study. Obes Res 2004; 12:725-733.
34. de Ferranti S, Rifai N. C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. Clin Chim Acta 2002; 317:1-15.
35. Rabbia F, Silke B, Conterno A, Grosso T, De Vito B, Rabbone I, Chiandussi L, Veglio F. Assessment of cardiaca autonomic modulation during adolescent obesity. Obes Res 2003; 11:541-548.
36. Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G, Lambert E. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006; 48:787-796.
37. Eikelis N, Schlaich M, Aggarwal A, Kaye D, Esler M. Interactions between leptin and the human sympathetic nervous system. Hypertension 2003; 41:1072-1079.
38. Guizar JM, Ahuatzin R, Amador N, Sanchez G, Romer G. Heart autonomic function in overweight adolescents. Indian Pediatr 2005; 42:464-469.
39. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005; 45:9-14.
40. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 1999; 17:555-560.
41. Karlsson C, Lindell K, Ottosson M, Sjostrom L, Carlsson B, Carlsson LM. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 1998; 83:3925-3929.
42. Giacchetti G, Faloia E, Sardu C, Camilloni MA, Mariniello B, Gatti C, Garrapa GG, Guerrieri M, Mantero F. Gene expression of angiotensinogen in adipose tissue of obese patients. Int J Obes Relat Metab Disord 2000; 24:S142-S143.
43. Segura J, Ruilope LM. Obesity, essential hypertension and renin-angiotensin system. Public Health Nutr 2007; 10:1151-1155.
44. Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 2004; 10:3621-3637.